SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-277306
Filing Date
2019-10-29
Accepted
2019-10-29 11:16:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d815350dsc13da.htm SC 13D/A 32445
  Complete submission text file 0001193125-19-277306.txt   34015
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Subject) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88577 | Film No.: 191175190
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 34TH STREET AND CIVIC CENTER BOULEVARD PHILADELPHIA PA 19004
Business Address 34TH STREET AND CIVIC CENTER BOULEVARD PHILADELPHIA PA 19004 267-426-6957
Children's Hospital of Philadelphia Foundation (Filed by) CIK: 0001632060 (see all company filings)

IRS No.: 232237932 | State of Incorp.: PA | Fiscal Year End: 0630
Type: SC 13D/A